Labiana Health H1 2026 attributable net profit falls 49% to EUR 940,000

• Labiana Health's H1 2026 attributable net profit fell 49% to EUR 940,000, hurt by non-recurring financial expenses from cancelling Miralta/Blantyre financing.
• Turnover rose 5% to EUR 41.3 million, while Animal Health turnover climbed 10% to EUR 20.77 million.
• The Animal Health division secured 10 new international licensing agreements covering 28 products.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Labiana Health SA published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.